Perimenstrual migraines and their response to preventive therapy with topiramate

Cephalalgia

Volumn 31, Issue 2, 2011, Pages 152-160

  Allais, Gianni ^a   Sanchez Del Rio, Margarita ^b   Diener, Hans Christoph ^c   Benedetto, Chiara ^a   Pfeil, Joop ^d   Schäuble, Barbara ^e   Van Oene, Joop ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b HOSPITAL RUBER INTERNACIONAL   (Spain)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d Estimate Medical Statistics ^*  (Netherlands)

^e JANSSEN CILAG GMBH   (Germany)

Author keywords

Aura; combined oral contraceptives; menstrually related migraine; preventive treatment; topiramate

Indexed keywords

ORAL CONTRACEPTIVE AGENT; TOPIRAMATE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL MIGRAINE; OPEN STUDY; ORAL CONTRACEPTION; PROPHYLAXIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; FRUCTOSE; HUMANS; MALE; MENSTRUATION DISTURBANCES; MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79751506259     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410378049     Document Type: Article

References (28)

1. Barbas NR and Schuyler EA Heredity, genes, and headache. Semin Neurol 2006 ; 26: 507-514. (Pubitemid 44631073)
2. Launer LJ, Terwindt GM and Ferrari MD The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999 ; 53: 537-542. (Pubitemid 29382048)
3. Lipton RB, Bigal ME, Diamond M., Freitag F., Reed ML, Stewart WF and AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 ; 68: 343-349.
4. Allais G., Castagnoli Gabellari I., De Lorenzo C., Mana O. and Benedetto C. Menstrual migraine: clinical and therapeutical aspects. Expert Rev Neurother 2007 ; 7: 1105-1120. (Pubitemid 47451018)
5. Lay CL and Broner SW Special considerations in the treatment of migraine in women. Semin Neurol 2006 ; 26: 217-222.
6. Somerville BW Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975 ; 25: 239-244.
7. Somerville BW Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975 ; 25: 245-250.
8. Stewart WF, Lipton RB, Chee E., Sawyer J. and Silberstein SD Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000 ; 55: 1517-1523.
9. MacGregor EA, Frith A., Ellis J., Aspinall L. and Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006 ; 67: 2154-2158. (Pubitemid 46035468)
10. Couturier EG, Bomhof MA, Neven AK and van Duijn NP Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003 ; 23: 302-308. (Pubitemid 36577949)
11. Granella F., Sances G., Allais G., et al. MIGR-003 Study Group. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004 ; 24: 707-716. (Pubitemid 39209074)
12. MacGregor EA and Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004 ; 63: 351-353. (Pubitemid 38971141)
13. Ramadan NM Current trends in migraine prophylaxis. Headache 2007 ; 47 (Suppl. 1). S52-S57.
14. Moja PL, Cusi C., Sterzi RR and Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005 ; CD002919.
15. Mulleners WM and Chronicle EP Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia 2008 ; 28: 585-597. (Pubitemid 351614940)
16. Brandes JL, Saper JR, Diamond M., et al. MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004 ; 291: 965-973. (Pubitemid 38543754)
17. Diener HC, Tfelt-Hansen P., Dahlof C., Laínez MJ, Sandrini G. and Wang SJ Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004 ; 251: 943-950. (Pubitemid 39119312)
18. Silberstein SD, Neto W., Schmitt J. and Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004 ; 61: 490-495. (Pubitemid 38923736)
19. Diener HC, Agosti R., Allais G., et al. TOPMAT-MIG-303 Investigators Group. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2007 ; 6: 1054-1062. (Pubitemid 350123606)
20. Headache Classification Committee of the International Headache Society. International classification of headache disorders. 2nd ed. Cephalalgia 2004 ; 24 (Suppl. 1). 8-160.
21. Reuter U., Sanchez Del Rio M., Diener HC, et al. Migraines with and without aura and their response to preventive therapy with topiramate. Cephalalgia 2010 ; 30: 543-551.
22. Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997 ; 17: 103-108. (Pubitemid 27166264)
23. Martin VT and Lipton RB Epidemiology and biology of menstrual migraine. Headache 2008 ; 48 (Suppl. 3). S124-S130.
24. Brandes JL The influence of estrogen on migraine: a systematic review. JAMA 2006 ; 295: 1824-1830.
25. Allais G. and Benedetto C. Update on menstrual migraine: from clinical aspects to therapeutical strategies. Neurol Sci 2004 ; 25 (Suppl. 3). S229-S231.
26. Allais G., Castagnoli Gabellari I., Airola G., et al. Headache induced by the use of combined oral contraceptives. Neurol Sci 2009 ; 30 (Suppl. 1). S15-S17.
27. MacGregor EA, Frith A., Ellis J., Aspinall L. and Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006 ; 67: 2159-2163. (Pubitemid 46035469)
28. Sulak P., Willis S., Kuehl T., Coffee A. and Clark J. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007 ; 47: 27-37. (Pubitemid 46096054)